Fastpath, Inc. v. Arbela Technologies Corp.

760 F.3d 816, 2014 WL 3685908, 2014 U.S. App. LEXIS 14161
Court of Appeals for the Eighth Circuit·Decided July 25, 2014·No. 13-2585·Published·Cited by 191 cases

Opinion

PERRY, District Judge.

Fastpath, Inc. sued Arbela Technologies Corp. for breach of a mutual confidentiality agreement. Arbela moved to dismiss for lack of personal jurisdiction. The district court 2 dismissed. Fastpath appeals. *819 Having jurisdiction under 28 U.S.C. § 1291, we affirm.

I

Fastpath, an Iowa corporation, develops and markets security software. Arbela is a California services and software corporation offering security software. Arbela has no office or employees in Iowa and conducts no business there.

After an Arbela employee saw a Fast-path display at a trade show in Atlanta, Georgia in 2010, Arbela emailed Fastpath in Iowa about the possibility of pursuing potential business opportunities together. In October of 2011, Arbela’s President and CEO Nima Bakhtiary visited Fastpath’s booth at a trade show in Las Vegas, Nevada and inquired about some of its software tools. In March of 2012, Bakhtiary and Fastpath’s Vice President Andy Snook were both guest speakers at a conference in Houston, Texas. After the conference, they discussed a potential partnership, and on May 7, 2012, Bakhtiary emailed Snook and proposed a conference call to discuss each company’s business capabilities. Snook agreed, and he and Bakhtiary exchanged emails to schedule the conference call.

The call took place on May 21, 2012, between Snook, who was in Iowa, and Bak-hiarty, who was not, and lasted about 30 minutes. During the call, the parties agreed to a “show and tell” webinar. Snook then emailed Arbela to schedule the webinar. Attached to Snook’s email was a proposed confidentiality agreement with a covenant not to compete. Arbela requested that the covenant be made mutual. Fastpath agreed, made the proposed changes to the agreement, and emailed it to Arbela. Arbela executed the agreement (“Agreement”), and then Fastpath signed it in Iowa.

The Agreement recites that its purpose is to facilitate the exchange of information “for the purpose of evaluating and negotiating a possible investment, acquisition, divestiture, partnership and/or joint venture transaction between” Arbela and Fastpath. The Agreement contains a confidentiality provision and a three-year covenant not to compete that is unlimited in geographic scope. It also provides that it “shall be construed and interpreted in accordance with the laws of the state of Iowa, without giving effect to its conflict of law provisions.” The Agreement does not contain a forum selection clause.

Instead of the webinar, Arbela attended a sales presentation made by Fastpath in Seattle, Washington to prospective customers. Arbela then emailed Fastpath about its potential client Hexcel. Fastpath discovered that Arbela was marketing a new product to Hexcel as an alternative to one of Fastpath’s products.

On February 20, 2013, Fastpath’s sales director participated in a conference call with Arbela at Arbela’s request. The next day, Fastpath watched from Iowa an interactive, public webinar presentation hosted by Arbela. During this webinar, Arbela discussed a product that Fastpath claims is in direct competition with one of its products, allegedly in breach of the Agreement. The parties never did any business together, and Arbela denies that any confidential information was ever exchanged under the Agreement.

Fastpath sued Arbela in Iowa state court for allegedly breaching the Agreement’s covenant not to compete. Arbela removed the action to federal district court and moved to dismiss for lack of personal jurisdiction. The district court granted the motion and dismissed the action, concluding that it lacked personal jurisdiction over Arbela.

II

“We review personal jurisdiction issues de novo.” K-V Pharm. Co. v. J. *820 Uriach & CIA, S.A, 648 F.3d 588, 591(8th Cir.2011). When personal jurisdiction is challenged by a defendant, the plaintiff bears the burden to show that jurisdiction exists. K-V Pharm., 648 F.3d at 591-92; Viasystems, Inc. v. EBM —Papst St. Georgen GmbH & Co., KG, 646 F.3d 589, 592 (8th Cir.2011); Miller v. Nippon Carbon Co., Ltd., 528 F.3d 1087, 1090 (8th Cir.2008); Dever v. Hentzen Coatings, 380 F.3d 1070, 1072 (8th Cir.2004); Epps v. Stewart Info. Servs. Corp., 327 F.3d 642, 647 (8th Cir.2003). To successfully survive a motion to dismiss challenging personal jurisdiction, a plaintiff must make a prima facie showing of personal jurisdiction over the challenging defendant. K-V Pharm., 648 F.3d at 591 (“To survive a motion to dismiss for lack of personal jurisdiction, a plaintiff must make a prima facie showing that personal jurisdiction exists....”); Steinbuch v. Cutler, 518 F.3d 580, 585 (8th Cir.2008) (“To survive a motion to dismiss, the plaintiff must state sufficient facts in the complaint to support a reasonable inference that defendants may be subjected to jurisdiction in the forum state.”); Epps, 327 F.3d at 647; Clune v. Alimak AB, 233 F.3d 538, 541 (8th Cir.2000). A plaintiffs prima facie showing “must be tested, not by the pleadings alone, but by affidavits and exhibits supporting or opposing the motion.” K-V Pharm., 648 F.3d at 592 (quoting Dever, 380 F.3d at 1072-73). Where no hearing is held on the motion, we must view the evidence in a light most favorable to the plaintiff and resolve factual conflicts in the plaintiffs favor; however, the party seeking to establish the court’s personal jurisdiction carries the burden of proof and that burden does not shift to the party challenging jurisdiction. Epps, 327 F.3d at 647.

Free access — add to your briefcase to read the full text and ask questions with AI

Fastpath, Inc. v. Arbela Technologies Corp., 760 F.3d 816, 2014 WL 3685908, 2014 U.S. App. LEXIS 14161 (8th Cir. 2014).

760 F.3d 816 (Fastpath, Inc. v. Arbela Technologies Corp.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related